|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.930 USD | -1.00% |
|
+12.81% | -50.35% |
| 06-17 | Lexeo Therapeutics Publishes Phase I/Ii Data for Lx2006 in Friedreich Ataxia in Jama Cardiology | CI |
| 06-15 | Lexeo Therapeutics, Inc. - Shareholder/Analyst Call |
| Market Cap | 387M 338M 313M 293M 549M 36.53B 552M 3.71B 1.44B 17.98B 1.45B 1.42B 62.43B | P/E 2026 * |
-4.16x | P/E 2027 * | -3.71x |
|---|---|---|---|---|---|
| Enterprise Value | 244M 213M 197M 185M 346M 23.03B 348M 2.34B 906M 11.34B 916M 897M 39.37B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 19.2x |
| Free-Float |
99.39% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Lexeo Therapeutics, Inc.
| 1 day | -1.00% | ||
| 1 week | +12.81% | ||
| Current month | -4.09% | ||
| 1 month | +10.04% | ||
| 3 months | -14.85% | ||
| 6 months | -52.37% | ||
| Current year | -50.35% |
| 1 week | 4.5 |  | 5.34 |
| 1 month | 4.03 | | 5.4 |
| Current year | 4.03 | | 10.75 |
| 1 year | 3.6 | | 10.99 |
| 3 years | 1.45 | | 22.33 |
| 5 years | 1.45 | | 22.33 |
| 10 years | 1.45 | | 22.33 |
| Manager | Title | Age | Since |
|---|---|---|---|
R. Townsend
CEO | Chief Executive Officer | 46 | 2019-12-31 |
Louis Tamayo
DFI | Director of Finance/CFO | 50 | 2025-08-14 |
| Chief Tech/Sci/R&D Officer | 62 | 2026-01-19 |
| Director | Title | Age | Since |
|---|---|---|---|
R. Townsend
BRD | Director/Board Member | 46 | 2019-12-31 |
| Chairman | 72 | 2020-12-31 | |
Mette Agger
BRD | Director/Board Member | 61 | 2020-10-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 05-17 | Sell | Chief Operating Officer | -1,302 | 0.0024% | ||
| 05-17 | Sell | Chief Executive Officer | -3,342 | 0.0062% | ||
| 04-27 | Free | Director | 50,000 | 0.0926% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.00% | +12.81% | +16.27% | - | 387M | |
| +1.44% | -1.25% | +63.52% | +114.88% | 55.19B | |
| +4.60% | +3.02% | +58.20% | +47.16% | 45.75B | |
| -1.44% | +0.39% | -12.94% | -19.24% | 22.98B | |
| -2.69% | -2.10% | -3.68% | +379.00% | 20.76B | |
| +3.22% | -0.84% | +27.88% | -34.00% | 16.26B | |
| +0.58% | +1.08% | +16.73% | -38.06% | 15.42B | |
| -1.01% | -2.30% | +27.42% | +171.92% | 13.05B | |
| +4.95% | +11.70% | +123.63% | +252.19% | 12.45B | |
| +3.07% | +0.14% | +29.37% | - | 12.37B | |
| Average | +1.17% | +3.75% | +34.64% | +109.23% | 21.46B | |
| Weighted average by Cap. | +1.62% | +1.50% | +40.87% | +99.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 6.11M 5.33M 4.93M 4.62M 8.66M 577M 8.72M 58.54M 22.69M 284M 22.94M 22.45M 986M |
| Net income | -98.85M -86.18M -79.82M -74.72M -140M -9.33B -141M -947M -367M -4.59B -371M -363M -15.94B | -122M -106M -98.19M -91.92M -172M -11.47B -173M -1.16B -451M -5.65B -456M -447M -19.61B |
| Net Debt | -143M -125M -115M -108M -203M -13.49B -204M -1.37B -531M -6.64B -537M -525M -23.06B | -270M -235M -218M -204M -382M -25.45B -385M -2.58B -1B -12.53B -1.01B -991M -43.49B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-18 | 4.930 $ | -1.00% | 1,481,284 |
| 26-06-17 | 4.980 $ | +4.84% | 1,421,115 |
| 26-06-16 | 4.750 $ | +2.15% | 724,365 |
| 26-06-15 | 4.650 $ | +6.41% | 2,464,303 |
| 26-06-12 | 4.370 $ | +4.05% | 625,037 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- LXEO Stock
Select your edition
All financial news and data tailored to specific country editions
